Radius Health

Skeletalis

This biotechnology company develops bone-targeted small-molecule therapies for patients with osteoporosis and other musculoskeletal diseases.

Crinetics

This pharmaceutical company develops oral therapeutics for patients with rare endocrine diseases and endocrine-related tumours.

Epicyt Pharma

This company develops pharmaceutical treatments to restore intestinal calcium absorption for patients with osteoporosis or those who have undergone gastric bypass surgery.

Ultragenyx

This biopharmaceutical company develops and commercialises therapies for patients with serious rare and ultra-rare genetic diseases.

Novadip Biosciences

This company develops regenerative tissue products to treat patients with large bone defects, non-union fractures and spinal fusion requirements.

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.

Zenas

This biopharmaceutical company develops and commercialises immunology-based therapies for patients with autoimmune diseases and rare fibroinflammatory conditions.

Amolyt Pharma

This clinical-stage biopharmaceutical company develops therapeutic peptides to treat patients with rare endocrine and related diseases, including hypoparathyroidism and acromegaly.